PMID- 26847674 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160205 LR - 20200930 IS - 2193-8253 (Print) IS - 2193-6536 (Electronic) IS - 2193-6536 (Linking) VI - 4 IP - 1 DP - 2015 Jun TI - Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case-Control Study. PG - 39-51 LID - 10.1007/s40120-015-0026-0 [doi] AB - INTRODUCTION: Aging of the population results in an increase in senior drivers. Elderly are frequently treated with benzodiazepines and antidepressants. The objective of this study was to determine whether the concurrent use of benzodiazepines and antidepressants is associated with motor vehicle accidents (MVAs) in the elderly. METHODS: This was a nested case-control study within a cohort of drivers aged 67-84 years between 1990 and 2000, identified from the Societe de l'Assurance Automobile du Quebec and the Regie de l'Assurance Maladie du Quebec databases. First cases of MVAs during follow-up were matched with up to ten controls from the cohort. Odds ratios (ORs) for the association between MVA and the use of benzodiazepines and antidepressants were estimated using conditional logistic regression. RESULTS: The cohort included 373,818 drivers, with 74,503 MVA cases matched with 744,663 controls. The risk of MVA was higher in current users of long-acting benzodiazepines [OR 1.23; 95% confidence interval (CI) 1.16-1.29] than in current users of short-acting benzodiazepines (OR 1.05; 95% CI 1.02-1.08). The risk of MVA was increased in current users of selective serotonin reuptake inhibitors (SSRIs; OR 1.13; 95% CI 1.04-1.22), while it was not in current users of tricyclic antidepressants (TCAs; OR 1.04; 95% CI 0.96-1.14). The highest ORs of MVA were observed in long-acting benzodiazepines users concurrently using SSRIs (OR 1.37; 95% CI 1.07-1.77, P value for interaction = 0.964) or TCAs (OR 1.54; 95% CI 1.21-1.95, P value for interaction = 0.077). CONCLUSION: Use of long-acting benzodiazepines is associated with an increased risk of MVA in the elderly, particularly in those concurrently using SSRIs or TCAs. FAU - Fournier, Jean-Pascal AU - Fournier JP AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada. AD - Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. FAU - Wilchesky, Machelle AU - Wilchesky M AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada. AD - Donald Berman Maimonides Geriatric Center, McGill University, Montreal, QC, Canada. AD - Department of Medicine, McGill University, Montreal, QC, Canada. FAU - Patenaude, Valerie AU - Patenaude V AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada. FAU - Suissa, Samy AU - Suissa S AD - Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada. samy.suissa@mcgill.ca. AD - Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. samy.suissa@mcgill.ca. LA - eng PT - Journal Article DEP - 20150306 PL - New Zealand TA - Neurol Ther JT - Neurology and therapy JID - 101637818 PMC - PMC4470976 OTO - NOTNLM OT - Aged OT - Antidepressants OT - Automobile driving OT - Benzodiazepines OT - Drug interactions EDAT- 2016/02/06 06:00 MHDA- 2016/02/06 06:01 PMCR- 2015/03/06 CRDT- 2016/02/06 06:00 PHST- 2014/12/12 00:00 [received] PHST- 2016/02/06 06:00 [entrez] PHST- 2016/02/06 06:00 [pubmed] PHST- 2016/02/06 06:01 [medline] PHST- 2015/03/06 00:00 [pmc-release] AID - 10.1007/s40120-015-0026-0 [pii] AID - 26 [pii] AID - 10.1007/s40120-015-0026-0 [doi] PST - ppublish SO - Neurol Ther. 2015 Jun;4(1):39-51. doi: 10.1007/s40120-015-0026-0. Epub 2015 Mar 6.